Related news and resources
R&D based biopharmaceutical industry statement in support of the Seventh Global Fund Replenishment
Ahead of the Global Fund Seventh Replenishment for 2024-2026, the innovative biopharmaceutical industry reaffirms its longstanding commitment to support the Global Fund mission to defeat HIV, TB, and malaria, and ensure a healthier, safer, more equitable future for all.
Read moreFighting for what counts: Leveraging the power of collaboration to end HIV, tuberculosis, and malaria
Leveraging the power of collaboration to end HIV, tuberculosis, and malaria.
Read more
Collaborating to end Neglected Tropical Diseases
Read more